Scholars Central

Research articlePublished 2014

Infarct Related Artery only Versus Multivessel Revascularization during Primary PCI for STEMI

Authors: Qarawani Dahud, Nahir Menachem, Ghasan Salameh, Yonathan Hasin

Clinical and Experimental Cardiology

Volume 5 · Issue 4 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Guidelines for ST Elevation Myocardial Infarction (STEMI) recommend for multivessel disease that only the culprit vessel be treated and that other diseased vessels be addressed in another time. Methods: STEMI patients with multivessel disease undergoing primary PCIs in our center between January 2001 and April 2011 were divided into: 1- Culprit only PCI and 2- Multivessel PCI during the index procedure. Mortality rates and clinical outcomes were compared between the two groups in hospital and at 12 months. Results: 491 patients had STEMI and multivessel disease. In 341 (69.5%) immediate multivessel PCI was performed, in 150 (30.5%) patients a culprit vessel only was treated and the rest was deferred for another procedure. Multivessel PCI was associated with Shorter hospitalization (4.4 ± 1.27 versus 7.6 ± 2.1, P=0.01), reduced incidence of 12 months major adverse cardiac events (recurrent ischemia, reinfarction, acute heart failure and mortality (16.1 versus 35.3%, P=0.01). A significant lower rate of recurrent ischemic episodes (5.6% versus 11.3%, P=0.02), myocardial reinfarction (5% versus 10%, P=0.01), reintervention (9.4% versus 26%, P=0.01). Transient renal dysfunction was more common in multivessel PCI (8.5% versus 4% P=0.01). In-hospital mortality (4.1% vs 4.4% p=0.9) was similar, while 1 year mortality tended to be decreased in the multivessel group (6.9% vs 7.4%), p=0.06). Conclusion: Multivessel revascularization resulted in an improved clinical course. Our findings support that multivessel PCI during STEMI can be feasible and safe. Decisions about PCI of the non-infarct vessel(s) should be individualized. Further large, randomized trials will help us solve this dilemma.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Qarawani Dahud”
  • BylineArticles whose byline prints “Nahir Menachem”
  • BylineArticles whose byline prints “Ghasan Salameh”
  • BylineArticles whose byline prints “Yonathan Hasin”